Author Question: Which of the following is a reason for firms not using the payback method as a guideline in capital ... (Read 96 times)

corkyiscool3328

  • Hero Member
  • *****
  • Posts: 539
Which of the following is a reason for firms not using the payback method as a guideline in capital investment decisions?
 
  A) It gives an explicit consideration to the timing of cash flows.
  B) It cannot be specified in light of the wealth maximization goal.
  C) It is a measure of risk exposure and projects the possibility of a calamity.
  D) It is easy to calculate and has intuitive appeal.

Question 2

Dividends paid to stockholders is tax deductible.
 
  Indicate whether the statement is true or false



cuttiesgirl16

  • Sr. Member
  • ****
  • Posts: 345
Answer to Question 1

B

Answer to Question 2

FALSE



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

Multiple experimental evidences have confirmed that at the molecular level, cancer is caused by lesions in cellular DNA.

Did you know?

Hippocrates noted that blood separates into four differently colored liquids when removed from the body and examined: a pure red liquid mixed with white liquid material with a yellow-colored froth at the top and a black substance that settles underneath; he named these the four humors (for blood, phlegm, yellow bile, and black bile).

Did you know?

As many as 20% of Americans have been infected by the fungus known as Histoplasmosis. While most people are asymptomatic or only have slight symptoms, infection can progress to a rapid and potentially fatal superinfection.

Did you know?

Once thought to have neurofibromatosis, Joseph Merrick (also known as "the elephant man") is now, in retrospect, thought by clinical experts to have had Proteus syndrome. This endocrine disease causes continued and abnormal growth of the bones, muscles, skin, and so on and can become completely debilitating with severe deformities occurring anywhere on the body.

Did you know?

Computer programs are available that crosscheck a new drug's possible trade name with all other trade names currently available. These programs detect dangerous similarities between names and alert the manufacturer of the drug.

For a complete list of videos, visit our video library